VEGFA and ovarian carcinoma: Analysis of among over 1,300 human ovarian cancers showed those with elevated VEGFA together with low miR‐128‐2 have the worst outcome, confirming the existence of an aggressive subset in which VEGFA is linked to miR‐128‐2 loss.